FibroBiologics, Inc. Common Stock (FBLG) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 234K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -234K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 5.07M | 2.36M | 5.04M | 4.49M | 4.53M | 3.71M | 3.35M | 3.22M | 3.45M | 2.48M | 2.05M | 2.09M | 2.27M | 1.3M | 911K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.12M | 1.79M | 2.25M | 2.45M | 2.75M | 2.36M | 2.14M | 2.25M | 2.49M | 1.71M | 1.48M | 1.55M | 1.79M | 959K | 684K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.95M | 797K | 2.79M | 2.04M | 1.78M | 1.36M | 1.21M | 975K | 960K | 773K | 571K | 547K | 478K | 345K | 227K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -234K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.07M | -2.59M | -5.04M | -4.49M | -4.53M | -3.71M | -3.35M | -3.22M | -3.45M | -2.48M | -2.05M | -2.09M | -2.27M | -1.3M | -911K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -11.85% | 30.23% | -50.3% | -39.27% | -31.33% | -49.68% | -63.35% | -54.04% | -52.32% | -90.18% | - | - | -148.63% | - | - |
| EBITDA | -4.83M | -2.36M | -4.81M | -4.28M | -4.37M | -3.56M | -3.21M | -3.08M | -3.31M | -2.35M | -1.94M | -1.99M | -2.17M | -1.21M | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -10.55% | 33.8% | -49.8% | -38.91% | -31.9% | -51.45% | -65.41% | -54.66% | -52.74% | -94.21% | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 237K | 234K | 231K | 206K | 161K | 153K | 143K | 140K | 137K | 130K | 112K | 99K | 96K | 94K | 911K |
| EBIT | -5M | -3.04M | -5.78M | -4.66M | -4.97M | -3.09M | -495K | 903K | -8.46M | -9.72M | -2.19M | -2.15M | -2.28M | -1.3M | -911K |
| Net Interest Income | 16K | -179K | 73K | 50K | 99K | 57K | 74K | 65K | 35K | -1K | 0 | -10K | -135K | -220K | -106.5K |
| Interest Income | 20K | 25K | 73K | 50K | 99K | 63K | 79K | 70K | 39K | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4K | 204K | 0 | 0 | 0 | 6K | 5K | 5K | 4K | 1K | 0 | 10K | 135K | 220K | 106.5K |
| Other Income/Expense | 68K | -654K | -740K | -168K | -435K | 613K | 2.85M | 4.12M | -5.01M | -7.24M | -141K | -67K | -150K | -220K | -106.5K |
| Pretax Income | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.02M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.02M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.68% | -4.68% | -1055.6% | -618.71% | 41.3% | 68.11% | 77.2% | 141.57% | -250.31% | -537.6% | - | - | -137.35% | - | - |
| Net Income (Continuing) | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.02M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.24 | -0.98 | -2.60 | -2.40 | -2.80 | -1.78 | -0.20 | 0.60 | -5.40 | -6.20 | -1.35 | -1.33 | -3.00 | -1.00 | -0.72 |
| EPS Growth % | 20% | 45.01% | -1200% | -500% | 48.15% | 71.26% | 85.19% | 145.11% | -80% | -517.53% | - | - | -316.67% | - | - |
| EPS (Basic) | -2.24 | -0.98 | -2.60 | -2.40 | -2.80 | -1.78 | -0.20 | 0.60 | -5.40 | -6.20 | -1.35 | -1.33 | -3.00 | -1.00 | -0.72 |
| Diluted Shares Outstanding | 2.23M | 2.23M | 2.15M | 1.93M | 1.83M | 1.74M | 1.68M | 1.64M | 1.56M | 1.59M | 1.62M | 1.62M | 1.62M | 1.52M | 1.41M |
| Basic Shares Outstanding | 2.23M | 2.23M | 2.15M | 1.93M | 1.83M | 1.74M | 1.68M | 1.64M | 1.56M | 1.59M | 1.62M | 1.62M | 1.62M | 1.52M | 1.41M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |